Effect of MCI-154 on calcium sensitivity of vascular smooth muscle and its mechanism in hemorrhagic shock in rats

OBJECTIVE: To observe the effects of new calcium sensitizer MCI-154 on calcium sensitivity of vascular smooth muscle following hemorrhagic shock (HS) in rats, and to explore its mechanism

Bibliographische Detailangaben
Veröffentlicht in:Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue. - 1998. - 17(2005), 1 vom: 06. Jan., Seite 7-11
1. Verfasser: Yang, Guang-ming (VerfasserIn)
Weitere Verfasser: Liu, Liang-ming
Format: Aufsatz
Sprache:Chinese
Veröffentlicht: 2005
Zugriff auf das übergeordnete Werk:Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue
Schlagworte:English Abstract Journal Article Research Support, Non-U.S. Gov't Pyridazines Vasodilator Agents MCI 154 98326-33-1 rho-Associated Kinases EC 2.7.11.1 Cyclic GMP-Dependent Protein Kinases mehr... EC 2.7.11.12 Protein Kinase C EC 2.7.11.13 Calcium SY7Q814VUP
LEADER 01000caa a22002652 4500
001 NLM152978046
003 DE-627
005 20250206034655.0
007 tu
008 231223s2005 xx ||||| 00| ||chi c
028 5 2 |a pubmed25n0510.xml 
035 |a (DE-627)NLM152978046 
035 |a (NLM)15636703 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a chi 
100 1 |a Yang, Guang-ming  |e verfasserin  |4 aut 
245 1 0 |a Effect of MCI-154 on calcium sensitivity of vascular smooth muscle and its mechanism in hemorrhagic shock in rats 
264 1 |c 2005 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
500 |a Date Completed 08.10.2009 
500 |a Date Revised 20.11.2014 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a OBJECTIVE: To observe the effects of new calcium sensitizer MCI-154 on calcium sensitivity of vascular smooth muscle following hemorrhagic shock (HS) in rats, and to explore its mechanism 
520 |a METHODS: The superior mesenteric artery (SMA) from HS model of rat was adopted to assay the calcium sensitivity via observing the contraction initiated by Ca2+ under depolarizing conditions (120 mmol/L K+) with isolated organ perfusion system. The experiment was conducted in two parts, the effects of MCI-154 on calcium sensitivity of vascular smooth muscle in HS, and to explore whether MCI-154 could regulate the calcium sensitivity through regulating Rho-kinase, protein kinase C (PKC) and protein kinase G(PKG) 
520 |a RESULTS: Compared with the normal control group, the cumulative dose-response curve of SMA to Ca2+ in shock group was shifted to the right, the maximal contraction to Ca2+ was decreased significantly (P<0.01). MCI-154(10(-7), 10(-6), 10(-5), 10(-4) mol/L) pretreatment further shift the cumulative dose-response curve of Ca2+ to the right as compared to shock group (P<0.01). These result suggested that calcium desensitization existed in the vascular smooth muscle following HS, and MCI-154 further decreased the calcium sensitivity. Angiotensin II and phorbol 12-myristate-13-acetate (PMA), the Rho-kinase agonist and PKC agonist, increased the calcium sensitivity, made the cumulative dose-response curve of Ca2+ shift to the left. After MCI-154(10(-5) mol/L) pretreatment, the dose-response curve of Ca2+ was shifted to the right as compared to Ang II and PMA alone group (P<0.01). But, KT-5823, the PKG antagonist, antagonized MCI-154-induced right shift of the dose-response curve of Ca2+. It was suggested that MCI-154 induced the decrease of calcium sensitivity might be related to Rho-kinase, PKC and PKG 
520 |a CONCLUSION: The calcium sensitivity of vascular smooth muscle following HS is significantly decreased, MCI-154 can further decrease calcium sensitivity. MCI-154 may regulate calcium sensitivity of vascular smooth muscle through Rho-kinase, PKC and PKG 
650 4 |a English Abstract 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 7 |a Pyridazines  |2 NLM 
650 7 |a Vasodilator Agents  |2 NLM 
650 7 |a MCI 154  |2 NLM 
650 7 |a 98326-33-1  |2 NLM 
650 7 |a rho-Associated Kinases  |2 NLM 
650 7 |a EC 2.7.11.1  |2 NLM 
650 7 |a Cyclic GMP-Dependent Protein Kinases  |2 NLM 
650 7 |a EC 2.7.11.12  |2 NLM 
650 7 |a Protein Kinase C  |2 NLM 
650 7 |a EC 2.7.11.13  |2 NLM 
650 7 |a Calcium  |2 NLM 
650 7 |a SY7Q814VUP  |2 NLM 
700 1 |a Liu, Liang-ming  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue  |d 1998  |g 17(2005), 1 vom: 06. Jan., Seite 7-11  |w (DE-627)NLM098227793  |x 1003-0603  |7 nnns 
773 1 8 |g volume:17  |g year:2005  |g number:1  |g day:06  |g month:01  |g pages:7-11 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 17  |j 2005  |e 1  |b 06  |c 01  |h 7-11